Show Parent

April

Antimicrobial peptides in the real world: implications for cystic fibrosis Hiemstra P. S. Eur Respir J 2007; 29: 617-618
Who's (still) afraid of talc? Noppen M. Eur Respir J 2007; 29: 619-621
Right ventricular ejection fraction and NT-proBNP are both indicators of wall stress in pulmonary hypertension Vonk Noordegraaf A., Westerhof N. Eur Respir J 2007; 29: 622-623
Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum Bucki R., Byfield F. J., Janmey P. A. Eur Respir J 2007; 29: 624-632
Resistance of quiescent and proliferating airway epithelial cells to H2O2 challenge Smit-de Vries M. P., van der Toorn M., Bischoff R., Kauffman H. F. Eur Respir J 2007; 29: 633-642
Mitochondrial dysfunction in COPD patients with low body mass index Rabinovich R. A., Bastos R., Ardite E., Llinas L., Orozco-Levi M., Gea J., Vilaro J., Barbera J. A., Rodriguez-Roisin R., Fernandez-Checa J. C., Roca J. Eur Respir J 2007; 29: 643-650
Use of different exhaled nitric oxide multiple flow rate models in COPD Roy K., Borrill Z. L., Starkey C., Hazel A. L., Morris J., Vestbo J., Singh D. Eur Respir J 2007; 29: 651-659
The role of nebulised budesonide in the treatment of exacerbations of COPD Gunen H., Hacievliyagil S. S., Yetkin O., Gulbas G., Mutlu L. C., In E. Eur Respir J 2007; 29: 660-667
Childhood adiposity predicts adult-onset current asthma in females: a 25-yr prospective study Burgess J. A., Walters E. H., Byrnes G. B., Giles G. G., Jenkins M. A., Abramson M. J., Hopper J. L., Dharmage S. C. Eur Respir J 2007; 29: 668-675
Respiratory heat and moisture loss is associated with eosinophilic inflammation in asthma Noble D. D., McCafferty J. B., Greening A. P., Innes J. A. Eur Respir J 2007; 29: 676-681
Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma Papi A., Paggiaro P. L., Nicolini G., Vignola A. M., Fabbri L. M., on behalf of the ... Eur Respir J 2007; 29: 682-689
Exposure to trichloramine and respiratory symptoms in indoor swimming pool workers Jacobs J. H., Spaan S., van Rooy G. B. G. J., Meliefste C., Zaat V. A. C., Rooyackers J. M., Heederik D. Eur Respir J 2007; 29: 690-698
Road tunnel air pollution induces bronchoalveolar inflammation in healthy subjects Larsson B-M., Sehlstedt M., Grunewald J., Skold C. M., Lundin A., Blomberg A., Sandstrom T., Eklund A., Svartengren M. Eur Respir J 2007; 29: 699-705
Diagnostic value of serum precipitins to mould antigens in active hypersensitivity pneumonitis Fenoglio C-M., Reboux G., Sudre B., Mercier M., Roussel S., Cordier J-F., Piarroux R., Dalphin J-C. Eur Respir J 2007; 29: 706-712
Safety and tolerability of bosentan in idiopathic pulmonary fibrosis: an open label study Gunther A., Enke B., Markart P., Hammerl P., Morr H., Behr J., Stahler G., Seeger W., Grimminger F., Leconte I., Roux S., Ghofrani H-A. Eur Respir J 2007; 29: 713-719
Cardiovascular and metabolic effects of CPAP in obese males with OSA Coughlin S. R., Mawdsley L., Mugarza J. A., Wilding J. P. H., Calverley P. M. A. Eur Respir J 2007; 29: 720-727
Automatic detection of sleep-disordered breathing from a single-channel airflow record Nakano H., Tanigawa T., Furukawa T., Nishima S. Eur Respir J 2007; 29: 728-736
NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension Blyth K. G., Groenning B. A., Mark P. B., Martin T. N., Foster J. E., Steedman T., Morton J. J., Dargie H. J., Peacock A. J. Eur Respir J 2007; 29: 737-744
Smoking and tuberculosis among silicotic patients Leung C. C., Yew W. W., Law W. S., Tam C. M., Leung M., Chung Y. W., Cheung K. W., Chan K. W., Fu F. Eur Respir J 2007; 29: 745-750
Economic evaluation of adherence to treatment guidelines in nonintensive care pneumonia Menendez R., Reyes S., Martinez R., de la Cuadra P., Manuel Valles J., Vallterra J. Eur Respir J 2007; 29: 751-756
Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax Gyorik S., Erni S., Studler U., Hodek-Wuerz R., Tamm M., Chhajed P. N. Eur Respir J 2007; 29: 757-760
Talc mediates angiostasis in malignant pleural effusions via endostatin induction Najmunnisa N., Mohammed K. A., Brown S., Su Y., Sriram P. S., Moudgil B., Loddenkemper R., Antony V. B. Eur Respir J 2007; 29: 761-769
Travel to high altitude with pre-existing lung disease Luks A. M., Swenson E. R. Eur Respir J 2007; 29: 770-792
Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms Holgate S. T., Davies D. E., Powell R. M., Howarth P. H., Haitchi H. M., Holloway J. W. Eur Respir J 2007; 29: 793-803
Master switches of T-cell activation and differentiation Beier K. C., Kallinich T., Hamelmann E. Eur Respir J 2007; 29: 804-812
Pulmonary arteriovenous fistula in a patient with renal cell carcinoma Kopetz S., Jimenez C., Tu S-M., Sharma P. Eur Respir J 2007; 29: 813-815
Relapsing necrotising sarcoid granulomatosis in a young patient Currie G. P., Kerr K. M., Legge J. S. Eur Respir J 2007; 29: 816
Angiotensin-converting enzyme genotype and C-reactive protein in patients with COPD Tkacova R., Joppa P. Eur Respir J 2007; 29: 816-817
Diffuse panbronchiolitis: East meets West McGrath E. E., McLaughlin A. M., FitzGerald M. X. Eur Respir J 2007; 29: 817-818
Exposure to second-hand smoke: a population-based survey in Spain Perez-Rios M., Santiago-Perez M. I., Alonso B., Malvar A., Hervada X. Eur Respir J 2007; 29: 818-819
Effect of spirometry on COPD management in primary care: where are the studies that we really need? Poels P. J. P., Schellekens D. P. A., Schermer T. R. Eur Respir J 2007; 29: 820
From the authors Walker P. P., Davies L. Eur Respir J 2007; 29: 821
Evidence-based medicines for children: ethical aspects Gammelgaard A., Bisgaard H. Eur Respir J 2007; 29: 821-822
From the author Bush A. Eur Respir J 2007; 29: 822
EXCESS MORTALITY IN PATIENTS WITH ASTHMA ON LONG-ACTING β2-AGONISTS J. HASFORD AND J.C. VIRCHOW Eur Respir J 2007; 29: 823
THE HUMAN LUNG: DID EVOLUTION GET IT WRONG? J.B. WEST, R.R. WATSON AND Z. FU Eur Respir J 2007; 29: 823